Epidarex Capital Partners Limited
Registered name: EPIDAREX CAPITAL PARTNERS LIMITED
Part of Epidarex Management Ltd groupEpidarex Capital Partners Limited does not publish its revenue or profit. Its accounts to 31 Mar 2026 show net assets of -£2.
Epidarex Capital Partners Limited did not publish its revenue or profit — small companies aren’t required to file a profit & loss account. Its accounts for the year to 31 Mar 2026 showed net assets of −£2 and 0 employees. The company is classified under “fund management activities” and is based in Edinburgh; we hold 5 years of its filed accounts.
- Status
- Active
- Location
- Edinburgh, Scotland
- Age
- 13 yrs · since 2012
- Type
- Private Limited Company
Pass-through vehicle. This looks like a holding, staffing or umbrella company. Its revenue and profit may largely pass through to or from other entities, so the figures may not reflect a standalone operating business. It is excluded from our opportunity lists.
Part of a group. The filing indicates this company sits within a group structure, so its results may depend on intra-group trading and it may be hard to replicate independently.
Key figures
Revenue not disclosed
Epidarex Capital Partners Limited’s accounts for the year to 31 Mar 2026 contain a balance sheet but no profit & loss account, so its revenue and profit are not public. UK small and micro-entity companies are not required to publish a P&L — this is normal and says nothing about how the business is performing.
We never estimate revenue. Below you’ll find the balance-sheet figures that were filed — useful as indirect signals of momentum, but they are not revenue or profit.
- Employees
- 0
- Net assets
- −£2
Badges are automated estimates derived from the filed figures — not statements of fact about the company.
Financial history
| Year to | 31 Mar 2022 | 31 Mar 2023 | 31 Mar 2024 | 31 Mar 2025 | 31 Mar 2026 |
|---|---|---|---|---|---|
| Disclosure | No P&L | No P&L | No P&L | No P&L | No P&L |
| Profit & loss | |||||
| Revenue (turnover) | — | — | — | — | — |
| Profit (best available) | — | — | — | — | — |
| Employees (average) | 0 | 0 | 0 | 0 | 0 |
| Ratios | |||||
| Profit margin | — | — | — | — | — |
| Balance sheet — indirect signals, not revenue | |||||
| Net assets | −£497k | −£2 | −£2 | −£2 | −£2 |
| Source | AbridgedAccounts · bulk data Dec 2023 | AbridgedAccounts · bulk data Dec 2023 | AbridgedAccounts · bulk data Dec 2024 | AbridgedAccounts · bulk data Oct 2025 | AbridgedAccounts · bulk data Sep 2026 |
Balance-sheet signals
Year-on-year changes in filed balance-sheet items. They can hint at momentum (or investment) but are not revenue or profit and must not be read as such.
- Net assets
- —
- Now −£2
- Cash at bank
- —
- Now —
- Headcount
- —
- Now 0
- Deferred income
- —
- Now —
- Fixed assets
- —
- Now —
Group structure
Ownership chain
- Epidarex Management Ltdultimate parent75–100%
- Epidarex Capital Partners Limitedthis company
Bands show the share of ownership each company holds in the one below it.
Subsidiaries (2)
- Adorx Therapeutics LimitedRev. £1.2m · Profit £211k
- Clyde Biosciences LimitedFigures not disclosed
Sister companies (1)
- Epidarex Partners LimitedFigures not disclosed
From the Persons with Significant Control register (corporate controllers only).
Sources
Latest figures from AbridgedAccounts for the year to 31 Mar 2026, from the Companies House accounts bulk data published Sep 2026. Spotted an error? Request a correction.
Updated from Companies House on 22 Oct 2026
Contains public sector information from Companies House licensed under the Open Government Licence v3.0. Data from Companies House, © Crown copyright. View the licence.